Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950159-11-000752
Filing Date
2011-11-14
Accepted
2011-11-14 16:23:07
Documents
11
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tengion10-q.htm 10-Q 1355945
2 EXHIBIT 31.1 ex31-1.htm EX-31.1 15027
3 EXHIBIT 31.2 ex31-2.htm EX-31.2 14265
4 EXHIBIT 32.1 ex32-1.htm EX-32.1 8117
5 EXHIBIT 32.2 ex32-2.htm EX-32.2 7238
  Complete submission text file 0000950159-11-000752.txt   3876814

Data Files

Seq Description Document Type Size
6 tngn-20110930.xml EX-101.INS 559318
7 tngn-20110930.xsd EX-101.SCH 25110
8 tngn-20110930_cal.xml EX-101.CAL 35857
9 tngn-20110930_def.xml EX-101.DEF 41068
10 tngn-20110930_lab.xml EX-101.LAB 276719
11 tngn-20110930_pre.xml EX-101.PRE 127952
Mailing Address 2900 POTSHOP LANE SUITE 100 EAST NORRITON PA 19403
Business Address 2900 POTSHOP LANE SUITE 100 EAST NORRITON PA 19403 267-960-4800
TENGION INC (Filer) CIK: 0001296391 (see all company filings)

EIN.: 200214813 | State of Incorp.: DE
Type: 10-Q | Act: 34 | File No.: 001-34688 | Film No.: 111202924
SIC: 2836 Biological Products, (No Diagnostic Substances)